Haleon plc (NYSE:HLN) Position Lowered by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. decreased its stake in shares of Haleon plc (NYSE:HLN) by 7.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 124,467 shares of the company’s stock after selling 9,933 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Haleon were worth $1,024,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Barclays PLC lifted its position in shares of Haleon by 56.4% during the second quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after purchasing an additional 1,196 shares during the last quarter. Hollencrest Capital Management lifted its position in shares of Haleon by 21.5% during the first quarter. Hollencrest Capital Management now owns 7,114 shares of the company’s stock worth $58,000 after purchasing an additional 1,258 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Haleon by 79.3% during the second quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock worth $25,000 after purchasing an additional 1,321 shares during the last quarter. Apollon Wealth Management LLC lifted its holdings in Haleon by 11.0% in the first quarter. Apollon Wealth Management LLC now owns 13,404 shares of the company’s stock worth $109,000 after acquiring an additional 1,332 shares during the last quarter. Finally, Financial Advocates Investment Management boosted its stake in Haleon by 10.5% in the third quarter. Financial Advocates Investment Management now owns 14,849 shares of the company’s stock valued at $124,000 after acquiring an additional 1,408 shares during the period. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Shares of HLN stock opened at $8.01 on Monday. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The business has a 50 day moving average of $8.32 and a two-hundred day moving average of $8.30. Haleon plc has a 52 week low of $7.70 and a 52 week high of $9.05. The company has a market cap of $36.57 billion, a P/E ratio of 28.61, a PEG ratio of 2.10 and a beta of 0.29.

Haleon Dividend Announcement

The business also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s payout ratio is currently 75.00%.

Analysts Set New Price Targets

Separately, Argus restated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.